Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIP.L Regulatory News (CIP)

  • There is currently no data for CIP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - CIP Merchant Capital Limited

6 Apr 2022 13:50

RNS Number : 5105H
Perseus Fund Ltd. (SAC) Class B
06 April 2022
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Perseus Fund Ltd. (SAC) Class B Special Opportunities Fund

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CIP Merchant Capital Limited

GG00BF8NW879

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

March 28, 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

710,000

1.29

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

710,000

1.29

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary

Sale

 

710,000

GBp 60.00

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

April 5, 2022

Contact name:

L. Michael Dean

 

Telephone number*:

+1 242 676 8185

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETDZGGDZVVGZZM
Date   Source Headline
17th Feb 20227:00 amRNSPartial Divestment of interest in Alkemy SpA
16th Feb 20227:00 amRNSForm 8.3 - CIP Merchant Capital Limited
15th Feb 20227:00 amRNSNet Asset Value(s)
14th Feb 202210:30 amRNSPublication of Defence Circular
11th Feb 20228:52 amRNSForm 8.3 - CIP Merchant Capital Limited
9th Feb 20229:39 amRNSForm 8.3 - CIP Merchant Capital Limited
8th Feb 20228:46 amRNSForm 8.3 - CIP Merchant Capital Ltd.
8th Feb 20227:00 amRNSNet Asset Value(s)
7th Feb 20228:34 amRNSForm 8.3 - CIP Merchant Capital Limited
4th Feb 202210:01 amRNSForm 8.3 - CIP Merchant Capital Limited
3rd Feb 20221:59 pmRNSForm 8.3 - CIP MERCHANT CAPITAL LIMITED
3rd Feb 20229:45 amRNSForm 8.3 - CIP Merchant Capital Ltd.
2nd Feb 202210:53 amRNSForm 8.3 - CIP Merchant Capital Limited
2nd Feb 20229:29 amRNSForm 8.3 - CIP Merchant Capital Ltd
1st Feb 20227:00 amRNSNet Asset Value(s)
31st Jan 202212:57 pmRNSForm 8.3 - CIP Merchant Capital Ltd
31st Jan 20229:06 amRNSStatement re Publication of CFE’s Mandatory Offer
31st Jan 20227:15 amRNSPosting of Offer Document
28th Jan 20226:05 pmRNSForm 8.3 - CIP Merchant Capital Ltd
28th Jan 202210:18 amRNSForm 8.3 - CIP Merchant Capital Limited
27th Jan 20224:34 pmRNSForm 8 (OPD) - CIP Merchant Capital Limited
27th Jan 20227:00 amRNSUnanimous Rejection of CFE’s Mandatory Cash Offer
26th Jan 202211:02 amRNSFurther Investment in Time Out Group plc
26th Jan 202210:14 amRNSForm 8.3 - C I P MERCHANT CAPITAL
26th Jan 20229:43 amRNSForm 8.3 - CIP Merchant Capital Limited
25th Jan 20229:51 amRNSForm 8.3 - CIP Merchant Capital Limited
25th Jan 20227:00 amRNSNet Asset Value(s)
24th Jan 202210:07 amRNSForm 8.3 - CIP Merchant Capital Limited
21st Jan 20228:48 amRNSForm 8.3 - CIP Merchant Capital Limited
20th Jan 20228:40 amRNSForm 8.3 - CIP Merchant Capital Limited
20th Jan 20227:00 amRNSForm 8 (OPD) - CIP Merchant Capital Limited
19th Jan 202210:28 amRNSForm 8.3 - CIP Merchant Capital Limited
18th Jan 20221:00 pmRNSForm 8.3 - CIP Merchant Capital Limited
18th Jan 20229:48 amRNSForm 8.3 - CIP Merchant Capital Limited
18th Jan 20227:00 amRNSNet Asset Value(s)
17th Jan 20227:00 amRNSResponse to Mandatory Cash Offer by CFE
17th Jan 20227:00 amRNSForm 8 (DD) - CIP Merchant Capital
14th Jan 20224:25 pmRNSOffer for CIP Merchant Capital Limited
11th Jan 20227:00 amRNSNet Asset Value(s)
5th Jan 20229:13 amRNSNet Asset Value(s)
30th Dec 20217:00 amRNSNet Asset Value(s)
29th Dec 20217:00 amRNSHolding(s) in Company
23rd Dec 20214:18 pmRNSInvestment in Aleva Neurotherapeutics SA
21st Dec 20217:00 amRNSNet Asset Value(s)
15th Dec 20214:02 pmRNSHolding(s) in Company
15th Dec 20217:00 amRNSInvestment in Time Out Group
14th Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20219:30 amRNSHolding in Company
9th Dec 20219:08 amRNSDivestment of Vertu Motors plc
7th Dec 20217:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.